Storia in 11 fonti

Novartis halts clinical trials following patient deaths

At the end of August, Novartis halted several clinical trials of experimental cell therapies for autoimmune diseases in the fields of immunology and neuroscience, following the deaths of three patients.

Raccontata da

www1.folha.uol.com.br

qz.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

swissinfo.chStai leggendo9 g fa

Novartis halts clinical trials following patient deaths

originale

Timeline cronologica

lunedì 31 agosto 2026·biopharmadive.com
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
The deaths of three study participants led Novartis to halt development of rap-cel in multiple indications, while “transient” side effects pushed Bristol Myers to voluntarily…
martedì 1 settembre 2026·endpoints.news
Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused
Novartis halts CAR-T trials after three patient deaths from an immune overreaction; Bristol Myers pauses zola-cel enrollment.

Novartis halts clinical trials following patient deaths

Confronto fonti

Novartis halts clinical trials following patient deaths

Timeline cronologica

Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns

Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused

Pharmakonzern Novartis stoppt nach Todesfällen mehrere Studien

Novartis pauses trials of experimental cell therapy after three deaths - Health - The Jakarta Post

Novartis, Bristol Myers halt autoimmune CAR-T trials after deaths

Novartis oprește mai multe studii clinice după decese în rândul pacienților - HotNews.ro

Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused

Novartis oprește mai multe studii clinice după decese în rândul pacienților - HotNews.ro

Novartis pauses trials of experimental cell therapy after three deaths - Health - The Jakarta Post

Novartis pausa ensaios de terapia voltada a distúrbios autoimunes e neurológicos após três mortes

Will Patient Deaths Derail the CAR-T Train in Autoimmune Disease?

Novartis halts clinical trials following patient deaths

Pharmakonzern Novartis stoppt nach Todesfällen mehrere Studien

Novartis suspende testes clínicos de medicamento para doenças autoimunes após morte de três pacientes

Novartis suspende testes de medicamento para doenças autoimunes após morte de três pacientes

Deaths in Novartis CAR-T trial force a reckoning over acceptable risk in autoimmune disease

Novartis, Bristol Myers halt autoimmune CAR-T trials after deaths